ATE78248T1 - Substituierte anilinderivate. - Google Patents

Substituierte anilinderivate.

Info

Publication number
ATE78248T1
ATE78248T1 AT86104488T AT86104488T ATE78248T1 AT E78248 T1 ATE78248 T1 AT E78248T1 AT 86104488 T AT86104488 T AT 86104488T AT 86104488 T AT86104488 T AT 86104488T AT E78248 T1 ATE78248 T1 AT E78248T1
Authority
AT
Austria
Prior art keywords
aniline derivatives
substituted aniline
alkylene
independently
antiarrhythmic
Prior art date
Application number
AT86104488T
Other languages
English (en)
Inventor
Jr John Guilfoyle Mullin
Keiji Nakamura
Jefferson Wright Tilley
Hiroshi Watanabe
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE78248T1 publication Critical patent/ATE78248T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
AT86104488T 1985-04-12 1986-04-02 Substituierte anilinderivate. ATE78248T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/722,650 US4696930A (en) 1985-04-12 1985-04-12 N-(heteroarylalkyl)acylanilide derivatives as antiarrhythmic agents
EP86104488A EP0198325B1 (de) 1985-04-12 1986-04-02 Substituierte Anilinderivate

Publications (1)

Publication Number Publication Date
ATE78248T1 true ATE78248T1 (de) 1992-08-15

Family

ID=24902766

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86104488T ATE78248T1 (de) 1985-04-12 1986-04-02 Substituierte anilinderivate.

Country Status (5)

Country Link
US (2) US4696930A (de)
EP (1) EP0198325B1 (de)
JP (1) JPH0699393B2 (de)
AT (1) ATE78248T1 (de)
DE (1) DE3685981T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2514855B2 (ja) * 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 光学活性なアラニンアニリド誘導体の酸付加塩

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US435921A (en) * 1890-09-09 Combined strainer and discharge-cock for varnish-tanks
US3409628A (en) * 1966-05-12 1968-11-05 Hoffmann La Roche 5-(3-pyridylethyl)pyridoindole derivatives
US3646045A (en) * 1968-09-10 1972-02-29 Hoffmann La Roche Intermediates for 5-(4-pyridylethyl)-pyridoindole derivatives
US4218477A (en) * 1971-07-28 1980-08-19 Astra Pharmaceutical Products, Inc. Primary aminoacylanilides, methods of making the same and use as antiarrhythmic drugs
BE787444A (fr) * 1971-08-13 1973-02-12 Hoffmann La Roche Composes polycycliques
US3812093A (en) * 1972-08-29 1974-05-21 Eastman Kodak Co Cationic thiadiazolyl monoazo dyes
DE2842284A1 (de) * 1978-09-28 1980-04-17 Bayer Ag N-diazolylalkyl-halogenacetanilide, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
DE2901593A1 (de) * 1979-01-17 1980-08-07 Basf Ag N-azolylessigsaeureanilide
US4336059A (en) * 1979-02-09 1982-06-22 Chevron Research Company Herbicidal and plant-growth-regulating N-(heterocyclyl)-methylacetanilide
DE2932643A1 (de) * 1979-08-11 1981-02-26 Bayer Ag N-pyrimidinylmethyl-halogenacetanilide, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
US4415587A (en) * 1981-06-19 1983-11-15 Berlex Laboratories, Inc. Method of use of antiarrhythmic 1-arylcarbamoylalkyl imidazole derivatives, composition
ZA84949B (en) * 1983-04-06 1984-09-26 American Cyanamid Co Substituted-n-(2-4-(1h-imidazol-1-yl)alkyl)substituted amides

Also Published As

Publication number Publication date
EP0198325B1 (de) 1992-07-15
EP0198325A2 (de) 1986-10-22
US4891429A (en) 1990-01-02
DE3685981D1 (de) 1992-08-20
JPH0699393B2 (ja) 1994-12-07
JPS61251664A (ja) 1986-11-08
DE3685981T2 (de) 1992-12-17
US4696930A (en) 1987-09-29
EP0198325A3 (en) 1987-10-07

Similar Documents

Publication Publication Date Title
ES8802518A1 (es) Un procedimiento para preparar derivados de isoxazol y furano.
SE8302694D0 (sv) Immunomodulating agent
DE3572170D1 (de) Quinolonecarboxylic acid derivatives
DE3882895T2 (de) Imid-Derivate, ihre Herstellung und Verwendung.
IN165718B (de)
DK0563798T3 (da) Butadienderivater og fremgangsmåder til fremstilling deraf
ATE78248T1 (de) Substituierte anilinderivate.
DE3572480D1 (de) 2-(3,5-dialkyl-4-hydroxyphenyl)indole derivatives
IE43651L (en) Benzisoquinolin-piperidine derivatives
ATE115567T1 (de) Verfahren zur herstellung von halogensulfonyl- substituierten pyridinen.
AU1586588A (en) Fungicidal derivatives of propenoic acid and processes for their preparation
ES8306733A1 (es) Derivados de anilina y sus sales.
GB8528234D0 (en) Heterocyclic compounds
AU5920486A (en) 6,9-epoxy-7-fluoro-11-hydroxy-prost-5-en-1-oic acid derivatives
EP0180416A3 (de) Benzoesäurederivate und deren Produktion
ES8201541A1 (es) Un procedimiento para la preparacion de nuevas guanilamidi- nas
IL86665A0 (en) Mitomycin analogs
ES2112470T3 (es) Derivados de piridazinona, procedimientos de produccion y utilizacion.
IL87107A (en) 2-(4-alkoxyphenyl)-5 (2-aminoethyl)-4-oxo- 3-naphtho- (2, 1b) -1,4-thiazepinone derivatives, their preparation and pharmaceutical compositions containing them
ATE66231T1 (de) Dioxolobenzisoxazolderivate und verfahren zu ihrer herstellung.
ES8603393A1 (es) Procedimiento para preparar composiciones fungicidas
ES8802384A1 (es) Procedimiento para 6-substituido-2-(1h) quinolinonas.
IE791153L (en) Imidazoline derivatives
TH1781A (th) อนุพันธุ์ของกรดอัลเคนไทโอคาร์บ๊อกซิลิค ที่มีกลุ่มแทนที่

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee